Cardiogen 20 mg

Subtotal	$0.00
Shipping	$0.00
Total	$0.00

Cardiogen 20 mg - Peptide Sciences USA Research Peptides

Active Substance: Cardiogen
Concentration: 20 mg per vial
Pack Size: Single vial (lyophilized powder)
Manufacturer: Peptide Sciences USA
Brand Name: Cardiogen
Molecular Formula: C₁₈H₃₁N₇O₉
Molecular Weight: 489.5 g/mol
Sequence: Ala-Glu-Asp-Arg

Manufacturer	Peptide Sciences USA
Brand	Cardiogen
Substance	Cardiogen
Concentration	20 mg
Pack Size	vial

Out of Stock

Research Peptides Description

Cardiogen 20 mg – The Sentinel of Heart Health Research

Product Summary

Imagine a research horizon where cardiac tissues regenerate, fibrosis diminishes, and new possibilities for cancer research emerge. Cardiogen 20 mg vial from Peptide Sciences USA, a bioregulatory tetrapeptide, delivers this potential. By targeting cardiac fibroblasts and cardiomyocytes, Cardiogen promotes heart repair, mitigates scar formation, and explores anti-cancer applications, empowering researchers to forge new paths in cardiovascular and longevity science.

How Cardiogen Works

Cardiogen is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Arg, designed to modulate fibroblast and cardiomyocyte activity. It stimulates cardiomyocyte proliferation while inhibiting fibroblast-driven scar formation, reducing cardiac fibrosis by up to 50% in rat models of ischemia-reperfusion injury. By downregulating p53 protein expression, Cardiogen inhibits apoptosis in cardiac cells, preserving heart function. Conversely, it may induce apoptosis in tumor cells, such as M-1 sarcoma in rats, by promoting hemorrhagic necrosis in tumor vasculature, suggesting anti-cancer potential.

Cardiogen also upregulates cytoskeletal proteins (actin, vimentin, tubulin) by 2–5x and nuclear matrix protein lamin A/C by 2–3x in HeLa cell cultures, stabilizing DNA and enhancing cell proliferation. Its synergy with standard cardiovascular therapies improves outcomes in heart attack and hypertension models, making it a versatile tool for researching cardiac repair, prostate health, and oncology.

Why Choose Cardiogen 20 mg?

Cardiogen is a cornerstone for cardiovascular and longevity research, offering transformative benefits. Here's why it stands out:

Heart Tissue Repair: Enhances cardiomyocyte proliferation, reducing fibrosis by up to 50% in ischemia models, supporting heart function recovery.
Anti-Fibrotic Action: Inhibits fibroblast activity, mitigating cardiac remodeling and heart failure progression in preclinical studies.
Anti-Cancer Potential: Induces tumor cell apoptosis in M-1 sarcoma models, opening avenues for sarcoma and prostate cancer research.
Therapeutic Synergy: Amplifies the efficacy of standard heart therapies, enhancing outcomes in cardiovascular disease models.
Superior Quality: Peptide Sciences USA ensures 99% purity through advanced synthesis, delivering reliable research results.

Cardiogen 20 mg empowers researchers to pioneer breakthroughs in heart health and longevity, backed by cutting-edge bioregulator peptide science.

Product Specifications

Peptide Sciences USA's Cardiogen 20 mg vial is crafted for precision in cardiovascular research, offering exceptional quality. Here's the breakdown:

Composition: Contains 20 mg of Cardiogen (C₁₈H₃₁N₇O₉, molecular weight 489.5 g/mol).
Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous or intramuscular injection.
Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
Usage Guidelines: Reconstitute with bacteriostatic water and administer via subcutaneous or intramuscular injection, typically at 0.1–0.5 mg/day in research protocols. Use under professional supervision.
Storage: Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
Safety: Preclinical studies report minimal side effects; limited human data requires research oversight.

This peptide is for research purposes only, providing a robust platform for studying cardiac repair and longevity.

Legal Disclaimer

Cardiogen 20 mg is supplied for research purposes only and is not FDA-approved for human use, though it is a candidate for sarcoma treatment in Russia. It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical research.

Frequently Asked Questions

What is Cardiogen used for?

Cardiogen is a bioregulatory tetrapeptide used in research to explore cardiovascular health, tissue repair, and anti-cancer effects. It targets fibroblasts and cardiomyocytes to enhance heart repair, reduce fibrosis, and investigate sarcoma treatment.

What are the benefits of Cardiogen peptide?

Cardiogen promotes cardiomyocyte proliferation, reduces cardiac fibrosis by up to 50%, enhances heart attack and hypertension therapy outcomes, and shows anti-cancer potential in sarcoma models.

What are Cardiogen side effects?

Preclinical studies report minimal side effects, with no significant toxicity observed. Limited human data necessitates professional oversight for research safety.

How is Cardiogen 20 mg administered in research?

Cardiogen is supplied as a 20 mg lyophilized powder. Reconstitute with bacteriostatic water and administer via subcutaneous or intramuscular injection, typically at 0.1–0.5 mg/day in research protocols, under professional guidance.

How should Cardiogen 20 mg be stored?

Store the lyophilized powder at -20°C. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 30 days to maintain potency.